U.S. Logistics Stock News

NasdaqGS:IPAR
NasdaqGS:IPARPersonal Products

Is Interparfums (IPAR) Fully Valued Following Strong Margins And Free Cash Flow?

Interparfums (IPAR) has drawn fresh attention after a session where the stock rose 3.4% to $115.67, helped by investor focus on its high gross margins, solid free cash flow, and recent outperformance. See our latest analysis for Interparfums. The recent 3.4% one day share price return and 10.9% 7 day share price return sit on top of a 25.2% 30 day share price return and 35.4% year to date share price return. In contrast, the 1 year total shareholder return is down 12.9% and the 3 year total...
NasdaqGS:HBNC
NasdaqGS:HBNCBanks

How Investors May Respond To Horizon Bancorp (HBNC) Jury Verdict And Indirect Auto Lending Exit

Horizon Bancorp recently recorded an approximate US$3.0 million pre-tax reserve after a June 24, 2026 jury awarded nearly US$3.0 million in damages against its Horizon Bank subsidiary over a 2018 indirect auto repossession and credit reporting dispute, and the company has said it plans to appeal the punitive component. An interesting wrinkle for investors is that Horizon had already exited most of its indirect auto lending exposure by 2024, and now characterizes the verdict as isolated with...
NYSE:DOLE
NYSE:DOLEFood

Is Dole (DOLE) Undervalued After Its Ecuador Port Sale?

Dole (NYSE:DOLE) has closed the sale of its port and port operations in Guayaquil, Ecuador, to TIL Switzerland Sàrl, receiving about US$75 million in cash after costs and transaction adjustments. See our latest analysis for Dole. Dole’s latest port sale comes after a period where the share price has eased, with the 90 day share price return down 5.7% and the year to date share price return down 6.15%. The 3 year total shareholder return is 12.26%, suggesting longer term holders have seen...
NYSE:BOW
NYSE:BOWInsurance

Bowhead Specialty (BOW) Is Up 7.3% After Shift Into Russell Value Indices What’s Changed

On 27 June 2026, Bowhead Specialty Holdings Inc. (NYSE: BOW) was reclassified across Russell indices, moving from growth benchmarks into several value-focused indices including the Russell 3000 Value and Russell 2000 Value. This shift in index membership highlights how the market now groups Bowhead more with value-oriented insurers, potentially affecting which institutional investors track or hold the stock. Next, we'll examine how this reclassification toward value indices interacts with...
NYSE:LYV
NYSE:LYVEntertainment

Live Nation Entertainment (LYV) Could Be 15% Undervalued Following Lowe's Partnership

Live Nation Entertainment (LYV) is back in focus after a multi-year partnership with Lowe's tied the concert giant to the retailer's loyalty program, while investors also weigh strong demand signals and unresolved antitrust remedies. See our latest analysis for Live Nation Entertainment. At a share price of $183.98, Live Nation Entertainment has seen momentum build over recent months, with a 30-day share price return of 7.94% and a 90-day gain of 18.13%. The 5-year total shareholder return of...
NYSE:CCI
NYSE:CCISpecialized REITs

Crown Castle (CCI) Moves Ahead With Tower Only Shift As Leadership Changes Take Shape

Crown Castle (NYSE:CCI) is advancing its plan to become a pure-play tower REIT. The company is pursuing the sale of its fiber and small-cell business as part of this shift. Recent executive leadership changes are aligned with the new tower-focused strategy. Crown Castle operates wireless towers and related infrastructure that support mobile connectivity for carriers and other customers. By concentrating on its tower portfolio and exiting the fiber and small-cell segment, the company is...
NasdaqGS:AMGN
NasdaqGS:AMGNBiotechs

Does Tavneos Retraction And Possible Withdrawal Reshape The Bull Case For Amgen (AMGN)?

The New England Journal of Medicine has retracted the pivotal Tavneos study and, following regulatory concerns over severe liver injuries, both the FDA and European regulators have moved toward withdrawing or revoking the drug’s approval. This rare combination of data integrity questions and potential market rollback raises broader concerns about Amgen’s clinical governance and risk controls in rare disease development. We’ll now examine how the threatened withdrawal of Tavneos may reshape...
NasdaqGS:JOYY
NasdaqGS:JOYYInteractive Media and Services

Should Awards for BIGO’s AI Ads and Governance Excellence Require Action From JOYY (JOYY) Investors?

Recently, JOYY’s BIGO Ads platform received a 2026 Sales and Marketing Excellence “Sammy” Award for its AI-driven, full-funnel advertising system, while JOYY was again named a “Most Honored Company” in Extel’s 2026 Asia Executive Team Survey for leadership and investor relations. Together, these awards spotlight JOYY’s operational capabilities in AI-powered advertising and its reputation for strong corporate governance and investor communication. We’ll now examine how BIGO Ads’...
NasdaqGM:SHLS
NasdaqGM:SHLSElectrical

Is Shoals Technologies Group (SHLS) Fully Valued Following The Proposed Chinese Inverter Ban?

Reports that the U.S. government is drafting a rule to ban imports of Chinese-made power inverters put Shoals Technologies Group (SHLS) in focus, as investors weighed how reduced foreign competition might influence its solar equipment business. See our latest analysis for Shoals Technologies Group. Against this policy backdrop, Shoals Technologies Group’s share price has been volatile, with a 1-day share price return of 2.22% and a 30-day share price return down 16.91%. However, a 90-day...
NasdaqGS:CAPR
NasdaqGS:CAPRBiotechs

Capricor Therapeutics (CAPR) Could Be 58% Undervalued Following FDA Focus And Index Removal

Capricor Therapeutics stock reacts to index removal and regulatory focus Capricor Therapeutics (CAPR) has come into focus after being removed from several Russell indices, just as investors track upcoming U.S. FDA advisory committee discussions on Deramiocel, its Duchenne muscular dystrophy cell therapy candidate. See our latest analysis for Capricor Therapeutics. Capricor Therapeutics shares have come under pressure in the short term, with the stock down 21.82% over seven days and 28.15%...
NYSE:NCLH
NYSE:NCLHHospitality

Is Norwegian Cruise Line Holdings (NCLH) Stock Cheap Or Reasonable Today?

Norwegian Cruise Line Holdings stock trades around US$20.67 after a mixed stretch for shareholders, with the market still pricing it as undervalued on earnings multiples even though the broader valuation checks only point to a partial bargain. The share price has fallen about 24% over the past 5 years, which means long term holders have not yet seen a recovery that clearly validates the current valuation. Improved sentiment around fuel costs and ongoing investment in its product offering can...
NYSE:ABR
NYSE:ABRMortgage REITs

Arbor Realty Trust (ABR) After Its Note Deal Faces A Fresh Valuation Test

Arbor Realty Trust (ABR) has just completed a private offering of US$325 million in 6.25% Convertible Senior Notes due 2029, a funding move that immediately reshaped how the stock is being discussed. See our latest analysis for Arbor Realty Trust. Arbor Realty Trust's recent capital moves come after a tough stretch for the stock. The latest share price is US$5.36, with a 7 day share price return of 5.30%, but a year to date share price return down 32.58% and a 1 year total shareholder return...
NasdaqGM:HRMY
NasdaqGM:HRMYPharmaceuticals

Is Harmony Biosciences Holdings (HRMY) A Bargain After Its Neuroscience Pipeline Push?

Recent coverage of Harmony Biosciences Holdings (HRMY) focuses on its effort to broaden beyond Wakix, with pitolisant studies in idiopathic hypersomnia and rare diseases, along with new neuroscience drug candidates that are drawing fresh investor attention. See our latest analysis for Harmony Biosciences Holdings. At a share price of US$36.00, Harmony Biosciences Holdings has seen a 30-day share price return of 13.17% and a 90-day share price return of 29.78%. Its 1-year total shareholder...
NYSE:ACEL
NYSE:ACELHospitality

Accel Entertainment (ACEL) After Russell 2000 Exit Has Undervaluation Back In Focus

Index removal puts Accel Entertainment back in focus Accel Entertainment (ACEL) was recently removed from the Russell 2000 Dynamic Index, an event that can influence institutional ownership patterns, index tracking fund flows, and short term trading activity around the stock. See our latest analysis for Accel Entertainment. Against that backdrop, Accel Entertainment’s recent share price moves have been mixed, with a 1-day share price return of 1.27% but a 7-day share price return that...
NYSE:MO
NYSE:MOTobacco

Altria Group (MO) As Steady Earnings Narratives Keep Fair Value In Focus

Altria Group (MO) is back in focus after recent share price moves, with the stock closing at US$71.54. Investors are weighing this action against its tobacco focused business mix and income profile. See our latest analysis for Altria Group. Recent trading has been slightly soft, with the share price slipping over the past day and week, but Altria Group still shows a 4.21% 30 day share price return and a 24.83% year to date share price return. Looking further out, total shareholder return sits...
NasdaqGS:PANW
NasdaqGS:PANWSoftware

Palo Alto Networks (PANW) Wins AI Backing And Upgrades, Is The Stock Fully Priced?

Investor sentiment around Palo Alto Networks (PANW) has shifted higher after strong Q3 revenue and annual recurring revenue figures, a wave of analyst upgrades, and new AI-focused collaborations with IBM and Red Hat. See our latest analysis for Palo Alto Networks. Palo Alto Networks’ recent AI-focused partnerships with IBM, Red Hat and Wipro have coincided with strong momentum in the stock, with a 7-day share price return of 23.41%, a 90-day share price return of 115.70% and a 5-year total...
NYSE:PINS
NYSE:PINSInteractive Media and Services

Pinterest (PINS) Stock Looks Discounted After A 72% Fall Yet Rich On Earnings

Pinterest has seen its share price fall 71.8% over the past five years, and the latest valuation checks suggest the stock still screens as expensive rather than a clear bargain despite that pullback. Over the past 5 years, Pinterest shareholders have seen the stock decline 71.8%, which puts more focus on whether today’s price now reflects the company’s risks and opportunities. On the upside, TD Cowen points to the potential for Pinterest’s Performance+ advertising solutions to support future...